We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MED market cap is 211.37M. The company's latest EPS is USD 9.1243 and P/E is 2.15.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 348.98M | 296.19M | 235.87M | 191.02M | 174.74M |
| Operating Income | 53.51M | 38.71M | 25.51M | 8.68M | 7.94M |
| Net Income | 39.97M | 30.28M | 23.13M | 6.04M | 8.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 713.67M | 934.84M | 1.53B | 1.6B | 1.07B |
| Operating Income | 91.04M | 134.16M | 216.24M | 184.81M | 126.4M |
| Net Income | 77.92M | 102.86M | 164.03M | 143.57M | 99.42M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 321.61M | 318.73M | 320.02M | 309.91M | 302.76M |
| Total Liabilities | 150.71M | 133.16M | 126.98M | 108.43M | 91.8M |
| Total Equity | 170.9M | 185.56M | 193.04M | 201.48M | 210.96M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 194.65M | 276.08M | 398.33M | 316.21M | 309.91M |
| Total Liabilities | 89.82M | 118.84M | 195.85M | 161.17M | 108.43M |
| Total Equity | 104.83M | 157.25M | 202.47M | 155.04M | 201.48M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 64.06M | 107.21M | 137.14M | 147.66M | 7.28M |
| Investing | -2.12M | -3.86M | -50.32M | -61.05M | -2.78M |
| Financing | -25.9M | -43.73M | -61.88M | -79.79M | -1.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 84.26M | 145.2M | 94.55M | 194.57M | 147.66M |
| Investing | -6.33M | -1.28M | -29.06M | -11.41M | -61.05M |
| Financing | -82.32M | -57.14M | -125.13M | -199.58M | -79.79M |
| Market Cap | 211.37M |
| Price to Earnings Ratio | 2.15 |
| Price to Sales Ratio | 0.2 |
| Price to Cash Ratio | 2.26 |
| Price to Book Ratio | 1.06 |
| Dividend Yield | 33.97% |
| Shares Outstanding | 10.9M |
| Average Volume (1 week) | 516.8k |
| Average Volume (1 Month) | 552.22k |
| 52 Week Change | -76.43% |
| 52 Week High | 109.52 |
| 52 Week Low | 19.33 |
| Spread (Intraday) | 2.54 (11.47%) |
| Company Name | Medifast Inc |
| Address |
3411 silverside road tatnall wilmington, delaware 19810 |
| Website | https://www.medifastinc.com |
| Industry | food preparations, nec (2099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
